Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis

2019 ◽  
Vol 24 (7) ◽  
pp. 891-901 ◽  
Author(s):  
Naser Tavakoli ◽  
Somayeh Taymouri ◽  
Anahita Saeidi ◽  
Vajihe Akbari
Keyword(s):  
Fungal Keratitis ◽  
Nanostructured Lipid Carriers ◽  
Potential Treatment ◽  
Thermosensitive Hydrogel

A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies

2018 ◽  
Vol 8 (5) ◽  
pp. 1226-1237 ◽  
Author(s):  
Mahboubeh Rezazadeh ◽  
Niloofar Jafari ◽  
Vajihe Akbari ◽  
Marjan Amirian ◽  
Majid Tabbakhian ◽  
...  
Keyword(s):  
Oral Mucositis ◽  
In Vivo Studies ◽  
Potential Treatment ◽  
Thermosensitive Hydrogel

Treatment of ebola and other infectious diseases: melatonin “goes viral”

2020 ◽  
Vol 3 (1) ◽  
pp. 43-57 ◽  
Author(s):  
Russel J Reiter ◽  
Qiang Ma ◽  
Ramaswamy Sharma
Keyword(s):  
Mortality Rate ◽  
Infectious Diseases ◽  
Hemorrhagic Shock ◽  
Safety Profile ◽  
Ebola Virus ◽  
Viral Infections ◽  
Virus Disease ◽  
Attractive Potential ◽  
Potential Treatment

This review summarizes published reports on the utility of melatonin as a treatment for virus-mediated diseases. Of special note are the data related to the role of melatonin in influencing Ebola virus disease. This infection and deadly condition has no effective treatment and the published works documenting the ability of melatonin to attenuate the severity of viral infections generally and Ebola infection specifically are considered. The capacity of melatonin to prevent one of the major complications of an Ebola infection, i.e., the hemorrhagic shock syndrome, which often contributes to the high mortality rate, is noteworthy. Considering the high safety profile of melatonin, the fact that it is easily produced, inexpensive and can be self-administered makes it an attractive potential treatment for Ebola virus pathology.  

CB4211 Is a Potential Treatment for Metabolic Diseases with a Novel Mechanism of Action—Sensitization of the Insulin Receptor

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 233-LB ◽  
Author(s):  
KENT GRINDSTAFF ◽  
REMI MAGNAN ◽  
ROBIN SHANG ◽  
EMILY STENGER ◽  
JENNA S. HOLLAND ◽  
...  
Keyword(s):  
Insulin Receptor ◽  
Mechanism Of Action ◽  
Metabolic Diseases ◽  
Potential Treatment
Sign in / Sign up

Export Citation Format

Share Document